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DERMAL CHEMICAL RESPONSE TO ANALOGUES OF DILANTIN*
J. C. bUCK, Pn.D.
Dilantin sodium is known to be able to produce
gingival hyperplasia (1) as well as to increase the
dermal concentration of insoluble collagen and
scleroprotein (2). Shafer (3) has indicated that
while most of the chemical analogues of Dilantin
were not capable of increasing the rate of fibro-
blast proliferation in tissue culture, additions of
either Dilantin, 1-allyl ,5 phenyl hydantoinate
or 5-methyl, 5 phenyl hydantoinate, into the in-
cubation media of fibroblasts did result in almost
identical degrees of stimulation of cell growth.
We have assayed the effects of these Dilantin
analogues upon the dermal chemistry of rats,
and compared the results with those obtained
from both normal and stressed control rats. The
results are presented below.
MATERIALs AND METHODS
Forty-eight male Sprague-Dawley rats (250—280
g) were divided into eight groups of six animals
each, and six of these groups were subjected to 10
daily intraperitoneal injections of 1.0 ml of iso-
tonic saline containing 25mg of one nf the fol-
lowing compounds in suspension: Dilantin,
sodium; 1-propyl-5 phenyl hydantoin (I);
5-methyl-S phenyl hydantoin (II); 3-methyl-5, 5
diphenyl hydantoin (III); 1-allyl-l-S phenyl
hydantoin (IV); 1, 5-dimethyl-5 phenyl hydantoin(V). One group of animals was subjected to 10
daily injections of isotonic saline alone, as a con-
trol of the stress of such injections (4). The final
group of rats was retained as controls. After 10
days, all animals were sacrificed and 2g samples of
abdominal skin were removed, shaven and dis-
sected clean of adhering fat, fascia and muscle.
These tissues were then minced and O.5g aliquots
removed. Other portions of the tissues were lyo-
philized for the gravimetric determination of
water. The remaining tissues from each group of
6 rats were pooled, and duplicate 4g samples of
pooled tissue were extracted sequentially in the
cold with 0.15M NaCl, 0.SM NaCl and 0.SM
citrate buffer (pH 3.6) as has been described pre-
viously (2, 5). These extractions have been shown
to remove quantitatively ground substance, neu-
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tral soluble and acid soluble collagen respec-
tively (5).
Both the extracts and the whole skin samples
were hydrolyzed in 4K HC1 at 1000 C. for 8 hours.
These hydrolysates were analysed in triplicate for
their nitrogen (6), hexosamine (7) and hydroxy-
proline (8) content as a measure of their protein,
mucopolysaceharides and glycoproteins (9) and
collagen (10) content. The difference between the
total dermal concentration of these materials and
the sum of their soluble concentrations was cal-
culated. The insoluble dermal concentration of
each material was therefore obtained. The results
were expressed as the mean of replicate analyses
and their standard deviations for each group of 6
animals in gzmoles of hexosamine or hydroxypro-
line or in mmoles of nitrogen per g of fresh, cleaned
rat skin. The standard deviations of either groups
of individual animals (totals) or of replicate analy-
ses of duplicate extracts prepared were never more
than 8% of the mean. Means differing by more
than two standard deviations were significantly
different (p < .05).
EXPERIMENTAL AND RESULTS
The results of the analysis of whole rat skin
after 10 daily intraperitoneal doses of the various
materials described above are presented in Table
I. This data indicates that only with the admin-
istration of cmpd. IV was there a marked in-
crease in dermal hydroxyproline concentration
equivalent to that produced by Dilantin, while
the stress control animals demonstrated a sig-
nificant decrease in dermal hydroxyproline con-
centration. The total hexosamine concentration
of the skin was essentially the same with all the
drugs studied, but only Dilantin administration
resulted in a profound increase in dermal ni-
trogen concentration. Compounds I, IV and V
all resulted in concentrations of total dermal
hydroxyproline and nitrogen which were sig-
nificantly above those found in the control ani-
mals, however.
Collagen is known to contain about lpmole
of hydroxyproline and about 13.3Mmoles of ni-
trogen per mg of protein (11). From the data of
Table I, the concentration of dermal collagen per
gm of fresh skin and the amount of collagenous
nitrogen may be obtained. The difference be-
tween this latter value and the total dermal
concentration of nitrogen is therefore due largely
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to non-collagenous protein, since the concentra-
tion of non-protein nitrogen has been shown to
be quite small in the tissue (5). Assuming that
non-collagenous dermal proteins contain 16%
nitrogen (11), then the concentration of these
proteins may also be obtained from the data of
Table I and expressed in terms of percent tissue
weight. Lyophilization of the various tissues per-
mitted the water content of the dermis to be
determined. The difference between the sum of
the collagen, protein and water content in per-
cent total weight of the skin and 100% must be
due to fat. These results are presented in Table
TABLE I
Analysis of whole rat skin after the administration
of 10 daily doses of various
Dilantin analogues
Compound Hypro Heat Nt
pmoles/g jtmoles/g snmsles/g
Control 190 10 7.5 .4 4.3 .2'
Dilantin 310 15 8.4 .5 8.1 .5
Cmpd. I 226 12* 8.5 .5 5.0 3*
Cmpd. II 193 12* 8.5 .5 5.0 3*
Cmpd. III 179 10* 7.2 4* 47 3*
Cmpd. IV 280 15 8.7 .4 5.5 3k
Cmpd. V 230 14* 8.4 .5 4.9 3*
Normal 240 15* 7.7 .4 4.9 3*
* Significantly different from Dilantin (p < .05).
t Hypro = hydroxyproline; Hex = hexosamine;N = nitrogen.
Italicized means are significantly different
from control (p < .05).
II, and show that none of the compounds used
could increase the dermal protein concentration
or decrease the water and fat concentration to
the same degree as did Dilantin. Only compounds
II and III resulted in a significant increase of
protein concentration above the control or nor-
mal concentration, while none of the compounds
resulted in any significant changes in dermal
weight or fat.
None of the compounds resulted in an increase
above control values in the concentration of
isotonic saline soluble hexosamine, or nitrogen
as shown in Table III, except Dilantin. There-
fore this ability of Dilantin to increase the con-
centration of "ground substance" appears to be
an unique property of this compound.
The concentration of neutral soluble collagen
in rat skin was significantly increased above con-
trol values by all of the drugs studied, as shown
in Table IV, although this increase was quan-
titatively less with Dilantin administration than
with the other compounds studied. Similarly
the amount of hexosamine found in the 0.51W
NaC1 fraction was increased above the control
with drug administration. This increase was es-
sentially similar for all drugs studied.
Citrate soluble collagen concentration, how-
ever, was decreased below the value of the con-
trols by Dilantin, whereas all the other deriva-
tives studied resulted in significant increases in
the dermal concentration of this material, as
shown in Table V. Again, only Dilantin admin-
istration resulted in significant amounts of hexos-
amine becoming soluble in this solvent.
TABLE II
The composition, in per cent fresh weight, of cleaned rat skin from animals after the administration of
10 daily doses of Dilantin analogues
Compound
% Composition
Collagen Protein water Fat
Control
Dilantin
Cmpd. I
Cmpd. II
Cmpd. III
Cmpd. IV
Cmpd. V
Normal
19.0 1.0*
31.0 1.5
22.6 1.2*
19.3 1.2*
17.9 1.0*
28.0 1.5
23.0 1.4*
24.0 1.5*
15.0 1.5*
36.0 3.7
17.4 1.8*
20.7 2.0*
28.1 2.7*
16.0 1.5*
17.0 1.5*
15.0 1.5*
55 5
30 3
50 4*
50 5*
45 4*
46 5*
50 5*
50 4*
11
3
10
10
9
10
10
11
* Significantly different from Dilantin (p < .05)
Italicized means significantly different from the control (p < .05)
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The difference between the sum of the soluble
materials described above, and the total dermal
concentration of each component permits the
calculation of the concentration of insoluble hy-
droxyproline, hexosamine and nitrogen to be
made. The effect of the various hydantoinates
and the trauma of injection upon the concentra-
tions of these insoluble materials is shown in
Table VI. Dilantin administration resulted in
profound increases in the amounts of insoluble
collagen and nitrogen; increases that were not
quantitatively duplicated by the five derivatives
TABLE III
Analysis of the 0.15 M NaCI extract of rat skin after
the administration of 10 daily doses of
various Dilantin analogues
Compound Hyprof Hexf Nt
jmo1es/g zmoles/g mmoles/g
Control 3.6 .2* 3.2 .2* 0.63 .03*
Dilantin 6.0 .4 4.3 .3 0.80 .04
Cmpd. I 4.2 •3* 2.7 .2* 0.56 .03*
Cmpd. II 4.2 •3* 2.0 .2* 0.62 .03*
Cmpd. III 1.8 .2* 2.4 .2* 0.51 .02*
Cmpd. IV 4.2 •3* 2.2 .2* 0.47 .02*
Cmpd. V 4.8 3* 2.6 .2* 0.56 .03*
Normal 4.7 3* 3.4 .2* 0.58 .04
* Significantly different from Dilantin (p <
.05).
t Hypro hydroxyproline; Hex = hexosamine;
N = nitrogen.
Italicized means are significantly different
from control (p < .05).
of this drug. Only compound IV resulted in a
significant increase in insoluble collagen concen-
tration above the control value, however, while
compounds II and IV did result in significant
increases above the control values of insoluble
dermal nitrogen.
The concentration of insoluble non-collage-
nous protein (scleroprotein) in these tissues was
calculated as described previously from the data
of Table VI, as were the ratios of collagen and
hexosamine to scieroprotein. These results, pre-
sented in Table VII, indicate that while there
was an increased amount of scleroprotein found
with the trauma of injection, the administration
of either Dilantin or compounds I, II, III and
IV resulted in increases in scleroprotein signifi-
cantly larger than that of the control. The degree
of increase in scleroprotein concentration pro-
duced by Dilantin was not equaled by the other
drugs, however. Again, Dilantin was unique in
its ability to increase the ratio of insoluble hexos-
amine to scleroprotein above that of the control.
DISCUSSION
The dermal chemical response to Dilantin ad-
ministration has been shown (2, 11) to involve
changes in four major components of rat skin:
1) an increase in total and insoluble collagen;
2) an increase in insoluble non-collagenous pro-
tein; 3) a decrease in dermal fat (12) and, 4) a
decrease in dermal water. Despite the ability of
compounds II and IV to increase the rate of
fibroblast proliferation (3), amounts of these
TABLE IV
Analysis of the 0.50 M NaC1 extract of rat skin after the administration of 10 daily doses of
various Dilantin analogues
Compound Hyprof Hext Nt
j.nwles/g ,.mo1e/g mmoles/g
Control 8.6 •4* 1.4 .1* 0.41 .02*
Dilantin 13.4 .7 2.3 .1 0.63 .03
Cmpd. I 23.4 1.8* 2.2 .1 0.56 .04
Cmpd. II 17.4 •7* 1.8 .1* 0.41 .02*
Cmpd. III 22.2 1.6* 1.8 .1* 0.51 .02*
Cmpd. IV 21.0 1.0* 2.6 .1 0.56 •Ø3*
Cmpd. V 29.0 .2* 2.2 .1 0.83 .04*
Normal 20.4 1.5* 1.6 .1* 0.70 .04
* Significantly different from Dilantin (p < .05).
f Hypro = hydroxyproline; Hex = hexosamine; N = nitrogen.
Italicized means are significantly different from control (p < .05).
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TABLE V
Analysis of the 0.5M citrate extract of rat skin after the administration of 10 daily doses of
various Dilantin, analogues
Compound Hyprot Hext Nt
zmoles/g mo1es/g mmoles/g
Control 27 1* 0* 0.82 .04*
Dilantin 19 1 0.43 .04 0.98 .05
Cmpd. I 42 2* 0* 0.93 .05
Cmpd. II 38 2* 0* 0.81 •Q4*
Cmpd. III 43 2* 0* 0.72 .04*
Cmpd. IV 48 2* 0* 0.81 .04*
Cmpd. V 61 3* 0* 1.32 .07*
Normal 8.0 .04* 0* 0.48 .02*
* Significantly different from Dilantin (p < .05).
f Hypro = hydroxyproline; Hex = hexosamine; N = nitrogen.
Italicized means are significantly different from control (p < .05).
TABLE VI
Analysis of the insoluble fractions of rat skin after
10 daily doses of varions
Dilantin analogues
Compound Hyprof Hexf Nf
pmoles/g ,moles/g mmoles/g
Control 153 12* 3.8 .3 2.5 .2*
Dilantin 274 15 3.5 .3 6.1 .8
Cmpd. I 156 11* 3.6 .2 2.9 .2*
Cmpd. II 133 10* 4.7 4* 3.2 .2*
Cmpd. III 112 9* 3.0 .2 2.8 .2*
Cmpd. IV 206 10* 3.9 .2 3.7 .2*
Cmpd. V 135 10* 3.6 .2 2.2 .2*
Normal 207 15* 3.0 .2 2.9 3*
* Significantly different from Dilantin (p <
.05).
t Hypro = hydroxyproline; Hex = hexosamine;N = nitrogen.
Italicizedmeans are significantly different from
control (p < .05).
derivatives equivalent to the concentration of
Dilantin usually employed did not produce the
same kind of changes in these components of the
connective tissue, either quantitatively or qual-
itatively as did Dilantin. Some of the compounds,
particularly IV, did result in significant increases
above the control in the concentration of in-
soluble collagen, however. It has been noted
previously (11) that changes in the dermal con-
centration of collagen and scieroprotein can pro-
ceed independently with Dilantin administration.
Therefore, it is possible that increases in the
TABLE VII
Non-collagenous sciero protein and insoluble
hexosamine and hydroxyproline in rat skin
after the administration of 10 daily
doses of Dilantin analogues
Compound Scieroprotein Hyprot/mg.scierot
Hext/mg.
sclero.f
mg/g
Control 40 4* 3.8 4* .09 .01*
Dilantin 210 20 1 .3 .1 .16 .01
Cmpd. I 70 8* 2.1 .2* .05 .01*
Cmpd. II 122 12* 1.1 .1 .04 .01*
Cmpd. III 114 10* 0.98 .1* .03 .01*
Cmpd. IV 88 9* 2.3 .2* .04 .01*
Cmpd. V 35 4* 3.9 4* .11 .01*
Normal 18 2* 11.5 1*
.14 .01
* Significantly different from Dilantin (p <
.05).
f Hypro = hydroxyproline in imoles/mg
scieroprotein; Hex = hexosamine in ,moles/mg
scleroprotein.
Italicized means are significantly different
from control (p < .05).
collagen content of the dermis need not neces-
sarily be associated with increases in scleropro-
tein concentration.
Since ten daily intraperitoneal injections of one
ml of isotonic saline into 250g rats have been
shown to result in a decrease in the concentration
of total and insoluble collagen (4), it is interesting
that animals treated in this manner with com-
pounds I, IV and V did not demonstrate losses
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of total collagen from the skin. However, only
compound IV was not associated with a loss of
insoluble collagen from the tissue.
Despite this "collagenizing" effect of compound
IV, it is obvious that none of the analogues of
Dilantin studied could quantitatively equal all
the changes in connective tissue chemistry pro-
duced by Dilantin itself. Therefore these ana-
logues either did not possess the same biological
properties as Dilantin, or their activities in these
directions were sufficiently small so that when
employed at doses equivalent to that of Dilantin
they were not demonstrable.
5UMMAEY
Five derivatives of Dilantin, including two
compounds which, like Dilantin, have been shown
to accelerate the proliferation of fibroblasts in
tissue culture (3), were found not to be able to
produce all the alterations in dermal chemistry
seen following Dilantin administration (2). The
administration of one of these derivatives,
1-allyl-5 phenyl hydantoin to whole animals re-
sulted in a significant increase in the dermal
concentration of insoluble collagen, but this
effect was considerably less than that produced
by similar amounts of Dilantin and the other
dermal chemical responses to Dilantin adminis-
tration were not demonstrated by this drug.
These results suggest that 1) increased fibro-
blast proliferation alone does not explain the
effects of Dilantin upon the connective tissue and
2) that these effects depend upon the unique and
precise structure of Dilantin rather than upon
hydantoin-like structures in general.
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